ArticleFrontiers in oncology2021

Immune Checkpoint Blockade Therapy May Be a Feasible Option for Primary Pulmonary Lymphoepithelioma-like Carcinoma.

Zuohong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.